Man Group
VERA icon

Man Group’s Vera Therapeutics VERA Stock Holding History

Man Group’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.16M Sell
50,346
-2,883
-5% -$107K ﹤0.01% 1534
2026
Q1 		$2.14M Buy
53,229
+20,865
+64% +$899K ﹤0.01% 1547
2025
Q4 		$1.64M Buy
+32,364
New +$1.15M ﹤0.01% 1519

Other funds holding VERA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Man Group's VERA Position: Q2 2026 in Review

Man Group reduced its Vera Therapeutics (VERA) stake by 5.4% in Q2 2026, selling an estimated $107K and leaving 50,346 shares worth $2.16M. The position accounts for ﹤0.01% of the portfolio, ranked #1534.

Man Group first reported a position in VERA in Q4 2025 and has held it in 3 quarters since. 220 funds tracked by Wall St. Rank hold VERA as of Q2 2026.

  • Man Group held 50,346 shares of Vera Therapeutics worth $2.16M as of Q2 2026.
  • Man Group sold 2,883 Vera Therapeutics shares in Q2 2026, an estimated $107K.
  • Vera Therapeutics made up ﹤0.01% of Man Group's portfolio in Q2 2026, its #1534 holding.
  • Man Group first reported a position in Vera Therapeutics in Q4 2025 and has held it in 3 quarters since.
  • 220 funds tracked by Wall St. Rank held Vera Therapeutics as of Q2 2026.

Based on Man Group's 13F filing for Q2 2026, filed 14 Aug 2026.